Results 201 to 210 of about 3,400,910 (254)

Clinical outcomes of carbon-ion radiotherapy for residual or recurrent hepatocellular carcinoma after transarterial chemoembolization. [PDF]

ESMO Gastrointest Oncol
Sekiguchi Y, Shibuya K, Tomogane S, Miyasaka Y, Kakizaki S, Okamoto M, Araki K, Shirabe K, Ohno T.   +8 more
europepmc   +1 more source

Application of intrahepatic fiducial markers in carbon ion radiotherapy for pancreatic cancer-Achieving higher precision treatment. [PDF]

J Appl Clin Med Phys
Nagata J, Kusano Y, Komori M, Takayama Y, Kurokawa S, Ito A, Kamada T, Yoshida D, Kawashiro S, Katoh H.   +9 more
europepmc   +1 more source

Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma. [PDF]

Int Cancer Conf J
Anzai H, Miwa C, Ogasawara S, Fujiya M, Kurosaki H, Tsuchiya T, Yoshino R, Katayama K, Sawada M, Akatsuka T, Izai R, Yonemoto T, Yumita S, Koroki K, Inoue M, Nakamura M, Kanogawa N, Nakamoto S, Makishima H, Shinoto M, Wakatsuki M, Yamada S, Ishikawa H, Kato J.   +23 more
europepmc   +1 more source

Real-World Outcomes of Combined Carbon-Ion Radiotherapy and Systemic Immunotherapy for Hepatocellular Carcinoma (Atezolizumab Plus Bevacizumab or Durvalumab Plus Tremelimumab): A Single-Center Retrospective Study. [PDF]

J Clin Med
Maki K, Haga H, Kaneko T, Hoshikawa K, Katsumi T, Suzuki F, Uchiyama F, Hanatani T, Hagiwara Y, Koto M, Ueno Y.   +10 more
europepmc   +1 more source

MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial. [PDF]

JHEP Rep
Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Fujiya M, Yumita S, Nakagawa M, Kanzaki H, Kobayashi K, Inoue M, Nakamura M, Kanogawa N, Kondo T, Nakamoto S, Kurokawa T, Ozawa Y, Inaba Y, Paritala S, Chen J, Lee J, Hoshida Y, Hanaoka H, Yamada S, Ishikawa H.   +24 more
europepmc   +1 more source

Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol. [PDF]

BMJ Open
Koroki K, Wakatsuki M, Ogasawara S, Makishima H, Watabe T, Anzai H, Fujiya M, Sawada M, Tsuchiya T, Katayama K, Yoshino R, Izai R, Akatsuka T, Miwa C, Yonemoto T, Yumita S, Inoue M, Nakamura M, Kanogawa N, Nakamoto S, Takahashi K, Ozawa Y, Inaba Y, Kurokawa T, Isozaki T, Takahashi A, Kato J, Ohtsuka M, Ohno T, Ueno Y, Furuse J, Kudo M, Hanaoka H, Ishikawa H.   +33 more
europepmc   +1 more source

Development and validation of NTCP models for predicting acute esophagitis in carbon ion radiotherapy for thoracic malignancies. [PDF]

BMC Cancer
Li Y, Zhang L, Liu Y, Ma N, Wu KL, Mao J, Chen J.   +6 more
europepmc   +1 more source

BCOR-CCNB3 fusion-positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up. [PDF]

Front Oncol
Oike N, Imai R, Ogose A, Ariizumi T, Murayama Y, Miyazaki T, Kimura K, Umezu H, Kawashima H.   +8 more
europepmc   +1 more source

Evaluation of Magnetic Resonance Imaging-Derived Synthetic Computed Tomography in Prostate Cancer Carbon Ion Radiotherapy: Impact of Fixation Shell. [PDF]

Int J Part Ther
Ishizawa M, Haga K, Sato H, Miyasaka Y, Souda H, Chai H, Iwai T.   +6 more
europepmc   +1 more source

AI-based prediction of recurrence after carbon ion radiotherapy for early stage non-small cell lung cancer. [PDF]

PLoS One
Miyasaka Y, Yoshida H, Okano N, Shimada H, Kubo N, Kawamura H, Ohno T.   +6 more
europepmc   +1 more source